Risk-Off for Biotech Trades… Update-2
4/1...at close ETF summary FBT at $116.87 down 1.15%, early support at $115. IBB at $340 touching bottom of upward channel, down 1%. XBI at $220.50 down 2.22%. At technical support. ETF leader with equal weight holdings in small and mid-caps. Another weak day for large caps ALXN, AMGN, BIIB,...
Snap-Back Rally In Biotech-But Lagging Other Sectors
Global Rally Today But Healthcare Sector Lags A Bit DOW up 1.49% at 17,976 NASDAQ Up 1.15% at 4947 Healthcare up 0.93% We are in Day Two of the biotech rally that was sparked last Friday with the rumor supported by a Deutsche Bank analyst that Biomarin (BMRN) was a takeover target. The Company...
Risk Off For Biotech Trades-BIIB, GILD, XBI…Update-2
Update 3/25 Mid-Day Trading NAZ Off 1.55% at 4917 "Bubble Talk" Picking Up-Mid Caps Vulnerable Biotech sector selling picked up today with a dramatic shift in sentiment exacerbated by an overall weak market. Also durable goods fell unexpectedly 1.4% in February indicating weak global...
NASDAQ Up -Biogen Idec Triggers Rally In Biotech
Biotech Stocks Are Soaring In Pre-Market Update at Mid Morning NASDAQ Up 39 to 5031 Healthcare Stocks Continue To Lead Biogen Idec (BIIB) Up 10% On Alzheimer Disease Phase 1 Data Encouraging Phase I data on aducanumab with 166 patients shows acceptable safety and amyloid plaque reduction...
Biotech Bull Market-Trends to Watch #2: ETF Review-FBT XBI
Biotech and Healthcare ETFs Hit An All Time High--Another Rally Coming Today 3/20 M&A: Recent buy-outs of Cubist (CBST) for $9.5B and Pharmacyclics (PCYC) for $21B have raised the valuation bar. The healthcare sector remains strong and biopharmaceuticals are key to sales growth....